Laura Lazo

Laura Lazo

Auto-generated profile, based on publicly available information

Laura Lazo


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2006 in Vaccine
Verified
Journal Article
Closed access
LHLisset Hermida
Lisset Hermida
LBLídice Bernardo
Lídice Bernardo
JMJorge Martín
Jorge Martín
MAMayling Alvarez
Mayling Alvarez
IPIrina Prado
Irina Prado
MGMaría G Guzmán
María G Guzmán

1 November 2009 in Virology
Verified
Journal Article
Closed access
IPIris Valdes Prado
Iris Valdes Prado
LBLidice Bernardo
Lidice Bernardo
LGLázaro Gil
Lázaro Gil
APAlekis Pavón
Alekis Pavón
LLLaura Lazo
Laura Lazo
LHLisset Hermida
Lisset Hermida

21 March 2009 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
CLCarlos López
Carlos López
LGLázaro Gil
Lázaro Gil
LLLaura Lazo
Laura Lazo
IMIvón Menéndez
Ivón Menéndez
EMErnesto Marcos
Ernesto Marcos
LHLisset Hermida
Lisset Hermida

1 January 2004 in Journal of Virological Methods
Verified
Journal Article
Closed access
LHLisset Hermida
Lisset Hermida
RRRayner Rodrı́guez
Rayner Rodrı́guez
LLLaura Lazo
Laura Lazo
RSRicardo Silva
Ricardo Silva
AZAida Zulueta
Aida Zulueta
GGGerardo Guillén
Gerardo Guillén

1 January 2007 in Vaccine
Verified
Journal Article
Closed access
LLLaura Lazo
Laura Lazo
LHLisset Hermida
Lisset Hermida
AZAida Zulueta
Aida Zulueta
JSJorge Sánchez
Jorge Sánchez
CLCarlos López
Carlos López
MGMaría G. Guzmán
María G. Guzmán

1 February 2009 in Viral Immunology
Verified
Journal Article
Closed access
LGLázaro Gil
Lázaro Gil
CLCarlos López
Carlos López
ABAracelys Blanco
Aracelys Blanco
LLLaura Lazo
Laura Lazo
JMJorge Martín
Jorge Martín
LHLisset Hermida
Lisset Hermida
For several years, researchers have known that the generation of neutralizing antibodies is a prerequisite for attaining adequate protection against dengue virus. Nevertheless, the cellular immune response is the principal arm of the adaptive immune system against non-cytopathic viruses such as dengue, as once the virus enters into the cell it is necessary to destroy it to eliminate the virus. To define the role of the cellular immune response in the protection against dengue, we selected the mouse encephalitis model. Mice were immunized with a single dose of infective dengue 2 virus and different markers of both branches of the induced adaptive immunity were measured. Animals elicited a broad antibody response against the four dengue virus serotypes, but neutralizing activity was only detected against the homologous serotype. On the other hand, the splenocytes of the infected animals strongly proliferated after in vitro stimulation with the homologous virus, and specifically the CD8 T-cell subset was responsible for the secretion of the cytokine IFN-γ. Finally, to define the role of T cells in in vivo protection, groups of animals were inoculated with the depleting monoclonal antibodies anti-CD4 or anti-CD8. Only depletion with anti-CD8 decreased to 50% the level of protection reached in the non-depleted mice. The present work constitutes the first report defining the role of the cellular immune response in protection against dengue virus in the mouse model.